Rising Prevalence of Hypogonadism is anticipated to boost the Growth of Testosterone Nasal Gels Market during 2021-2031

Published By Pressat [English], Tue, Nov 23, 2021 4:28 AM


According to the latest research by Fact MR, the testosterone nasal gels market will experience substantial growth with a CAGR of 3% during the forecast period 2021-2031.

Fact.MR – A Market Research and Competitive Intelligence Provider: The testosterone nasal gels market will experience substantial growth with a CAGR of 3% during the forecast period 2021-2031.

Testosterone replacement therapy is used to treat hypogonadism and other diseases like Klinefelter syndrome. Supplements containing testosterone are given throughout this therapy.

The rise in prevalence of hypogonadism, new product releases, and cooperation among players are all increasing demand for testosterone nasal gels. Klinefelter syndrome is one of the most frequent chromosomal diseases in infants, affecting one out of every 500 to 1000 babies, according to a survey.

To Get In-depth Insights Request for Brochure here – study offers insights into key trends affecting healthcare industry, subsequently influencing demand supply forces in the Testosterone Nasal Gels market. To study competitive trends, it profiles some of the leading market players profiling leading players including Acerus Pharmaceuticals Corporation, Hyundai Pharm Co., Endo Pharmaceuticals Inc.

To offer an in-depth analysis of prevailing competition, the report offers a detailed market share analysis. Strategies adopted by players across these categories and impact of the same on the overall market are studied at length.

Request Customized Report as Per Your Requirements – North American region dominates the market. This is owing to the market's presence of a large player. Acerus Pharmaceuticals Corporation, based in Canada, manufactures Natesto, the only FDA-approved testosterone nasal gel. The corporation collaborates with other companies to sell its goods globally in order to increase sales.

A study conducted by the University of Mersin and the Mersin City Education and Research Hospital in Turkey found that males affected with COVID-19 showed a decrease in testosterone levels. It showed that as the severity of COVID increased, the total testosterone levels decreased leading to hypogonadism. Therefore, this will surge the demand for testosterone replacement therapy hence driving the market.

Dual Migraine Treatment Market - The demand for dual migraine treatment market is anticipated by the factors such as increased migraine occurrences, expanding female population, patent endurance and stressful living styles promote the growth of the migraine therapeutics industry. Know more at Scale Bioreactors Market - Lab scale bioreactors are highly important as they help in production of stem cells. In addition, North America has the major biomedical industries which in turn helps in taking this market at the highest level globally. Know more at Turbidimetric Immunoassays Market - Particle-Enhanced Turbidimetric Immunoassays or PETIA is a biochemical process which uses optical change i.e. change in opaqueness caused by the agglutination of immunoparticles in the sample. Know more at research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. We are headquartered in Dubai, and operate from our sales office in Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.

Press release distributed by Media Pigeon on behalf of Pressat, on Nov 23, 2021. For more information subscribe and follow


Alison Lancaster

Editorial
[email protected]